$NPHC Closed UP 14.47%- More Coming- Analysis Coverage- an emerging biotechnology company with both a traditional drug line path, which will require further development, clinical trials, and FDA approvals, and an over-the-counter pain reliever, which is clinically proven to treat moderate to severe pain and chronic pain.http://globalsmallcaps.com/2017/02/14/nutra-pharma-corp/

The Company was recently featured in NBC news. The interview is here: www.tinyurl.com/nyloxinNBC